chr3-8990718-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_014850.4(SRGAP3):āc.2680A>Gā(p.Ser894Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000897 in 1,611,726 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0048 ( 7 hom., cov: 33)
Exomes š: 0.00049 ( 7 hom. )
Consequence
SRGAP3
NM_014850.4 missense
NM_014850.4 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 3.88
Genes affected
SRGAP3 (HGNC:19744): (SLIT-ROBO Rho GTPase activating protein 3) Predicted to enable GTPase activator activity. Predicted to be involved in negative regulation of cell migration. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0051725805).
BP6
Variant 3-8990718-T-C is Benign according to our data. Variant chr3-8990718-T-C is described in ClinVar as [Benign]. Clinvar id is 729048.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00482 (734/152294) while in subpopulation AFR AF= 0.0163 (677/41584). AF 95% confidence interval is 0.0153. There are 7 homozygotes in gnomad4. There are 361 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 734 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRGAP3 | NM_014850.4 | c.2680A>G | p.Ser894Gly | missense_variant | 21/22 | ENST00000383836.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRGAP3 | ENST00000383836.8 | c.2680A>G | p.Ser894Gly | missense_variant | 21/22 | 1 | NM_014850.4 | P1 | |
SRGAP3 | ENST00000360413.7 | c.2608A>G | p.Ser870Gly | missense_variant | 21/22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00483 AC: 735AN: 152176Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
735
AN:
152176
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00123 AC: 294AN: 239584Hom.: 1 AF XY: 0.000984 AC XY: 129AN XY: 131164
GnomAD3 exomes
AF:
AC:
294
AN:
239584
Hom.:
AF XY:
AC XY:
129
AN XY:
131164
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000487 AC: 711AN: 1459432Hom.: 7 Cov.: 32 AF XY: 0.000430 AC XY: 312AN XY: 725848
GnomAD4 exome
AF:
AC:
711
AN:
1459432
Hom.:
Cov.:
32
AF XY:
AC XY:
312
AN XY:
725848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00482 AC: 734AN: 152294Hom.: 7 Cov.: 33 AF XY: 0.00485 AC XY: 361AN XY: 74478
GnomAD4 genome
AF:
AC:
734
AN:
152294
Hom.:
Cov.:
33
AF XY:
AC XY:
361
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
48
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
168
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
SRGAP3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at